Amyloidogenic light chains impair plasma cell survival.

Marjorie Pick1, Eyal Lebel2, Sharona Elgavish3

  • 1Department of Hematology, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem. marjorie@cc.huji.ac.il.

Haematologica
|June 29, 2023
PubMed
Summary

Systemic light chain amyloidosis (AL) involves misfolded proteins. New cell models reveal AL cells have reduced proliferation and increased stress, explaining their unique behavior and aiding treatment development.